<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35030980</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2150-5608</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Virulence</Title>
          <ISOAbbreviation>Virulence</ISOAbbreviation>
        </Journal>
        <ArticleTitle>TNF-α response in macrophages depends on clinical <i>Legionella pneumophila</i> isolates genotypes.</ArticleTitle>
        <Pagination>
          <StartPage>160</StartPage>
          <EndPage>173</EndPage>
          <MedlinePgn>160-173</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21505594.2021.2022861</ELocationID>
        <Abstract>
          <AbstractText>Legionnaires' Disease (LD) is a severe pneumonia mainly caused in Europe by <i>Legionella pneumophila</i> serogroup 1 (Lp1). Sequence-based typing methods reveal that some sequence types (ST) are overrepresented in clinical samples such as ST1 and ST47, suggesting that some strains are more fit for infection than others. In the present study, a collection of 108 Lp1 clinical isolates were used to evaluate the strain-dependent immune responses from human macrophages. Clinical Lp1 isolates induced differential TNFα secretion from macrophages. ST1 isolates induced a significantly higher TNF-α secretion than non-ST1, whereas ST47 isolates induced a significantly lower TNF-α secretion than non-ST47 isolates. ST1 isolates induced a significantly higher cell death than ST47 isolates evaluated by lactate dehydrogenase activity (cytotoxicity) and caspase-3 activity (apoptosis). Treatment of macrophages with anti-TNF-α antibodies significantly reduced the cell death in macrophages infected with ST1 or ST47 strains. The TNF-α secretion was neither explained by a differential bacterial replication nor by the number or type (bystander or infected) of TNF-α producing cells following infection but by a differential response from macrophages. The Paris ST1 reference strain elicited a significantly higher <i>TNF-α</i> gene transcription and a higher induction of NF-κB signaling pathway than the Lorraine ST47 reference strain.Clinical Lp1 isolates induce a diverse immune response and cell death, which could be related to the genotype. The two predominant sequence-types ST1 and ST47 trigger opposite inflammatory response that could be related to the host susceptibility.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Guillemot</LastName>
            <ForeName>Johann</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-5902-9188</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ginevra</LastName>
            <ForeName>Christophe</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-5597-094X</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hospices Civils de Lyon, Institut Des Agents Infectieux, Centre National de Référence Des Légionelles, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Allam</LastName>
            <ForeName>Camille</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0003-4585-4651</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hospices Civils de Lyon, Institut Des Agents Infectieux, Centre National de Référence Des Légionelles, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kay</LastName>
            <ForeName>Elisabeth</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0002-8763-7076</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gilbert</LastName>
            <ForeName>Christophe</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0003-3021-7350</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doublet</LastName>
            <ForeName>Patricia</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0001-5848-4317</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jarraud</LastName>
            <ForeName>Sophie</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-5750-0215</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hospices Civils de Lyon, Institut Des Agents Infectieux, Centre National de Référence Des Légionelles, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chapalain</LastName>
            <ForeName>Annelise</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-3270-0947</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Virulence</MedlineTA>
        <NlmUniqueID>101531386</NlmUniqueID>
        <ISSNLinking>2150-5594</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000079424">Tumor Necrosis Factor Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016952" MajorTopicYN="Y">Legionella pneumophila</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007877" MajorTopicYN="Y">Legionnaires' Disease</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000079424" MajorTopicYN="N">Tumor Necrosis Factor Inhibitors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Legionella pneumophila</Keyword>
        <Keyword MajorTopicYN="Y">ST1</Keyword>
        <Keyword MajorTopicYN="Y">ST47</Keyword>
        <Keyword MajorTopicYN="Y">TNF-α</Keyword>
        <Keyword MajorTopicYN="Y">cell death</Keyword>
        <Keyword MajorTopicYN="Y">clinical isolates</Keyword>
        <Keyword MajorTopicYN="Y">immune response</Keyword>
        <Keyword MajorTopicYN="Y">macrophages</Keyword>
        <Keyword MajorTopicYN="Y">sequence type</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>15</Day>
          <Hour>5</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35030980</ArticleId>
        <ArticleId IdType="pmc">PMC8765069</ArticleId>
        <ArticleId IdType="doi">10.1080/21505594.2021.2022861</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Mondino S, Schmidt S, Rolando M, et al. Legionnaires’ disease: state of the art knowledge of pathogenesis mechanisms of Legionella. Annu Rev Pathol. 2020;15(1):439–466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31657966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chauhan D, Shames SR.. 
Pathogenicity and virulence of Legionella: intracellular replication and host response. Virulence. 2021;12(1):1122–1144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8043192</ArticleId>
            <ArticleId IdType="pubmed">33843434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campese C, Bitar D, Jarraud S, et al. Progress in the surveillance and control of Legionella infection in France, 1998-2008. Int J Infect Dis. 2011;15:e30–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21109475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lanternier F, Tubach F, Ravaud P, et al. Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study. Chest. 2013;144(3):990–998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23744173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beaute J. The European Legionnaires’ Disease Surveillance N. Legionnaires’ disease in Europe, 2011 to 2015. Euro Surveill. 2017;22(27). DOI:10.2807/1560-7917.ES.2017.22.27.30566</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.27.30566</ArticleId>
            <ArticleId IdType="pmc">PMC5508329</ArticleId>
            <ArticleId IdType="pubmed">28703097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cecchini J, Tuffet S, Sonneville R, et al. Antimicrobial strategy for severe community-acquired legionnaires’ disease: a multicentre retrospective observational study. J Antimicrob Chemother. 2017;72(5):1502–1509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28204479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chidiac C, Che D, Pires-Cronenberger S, et al. Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J. 2012;39(4):963–970.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22005914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cazalet C, Jarraud S, Ghavi-Helm Y, et al. Multigenome analysis identifies a worldwide distributed epidemic Legionella pneumophila clone that emerged within a highly diverse species. Genome Res. 2008;18(3):431–441.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2259107</ArticleId>
            <ArticleId IdType="pubmed">18256241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mercante JW, Caravas JA, Ishaq MK, et al. Genomic heterogeneity differentiates clinical and environmental subgroups of Legionella pneumophila sequence type 1. PLoS One. 2018;13(10):e0206110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6193728</ArticleId>
            <ArticleId IdType="pubmed">30335848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaia V, Fry NK, Afshar B, et al. Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila. J Clin Microbiol. 2005;43(5):2047–2052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1153775</ArticleId>
            <ArticleId IdType="pubmed">15872220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>David S, Rusniok C, Mentasti M, et al. Multiple major disease-associated clones of Legionella pneumophila have emerged recently and independently. Genome Res. 2016;26(11):1555–1564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5088597</ArticleId>
            <ArticleId IdType="pubmed">27662900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown AS, Yang C, Hartland EL, et al. The regulation of acute immune responses to the bacterial lung pathogen Legionella pneumophila. J Leukoc Biol. 2017;101(4):875–886.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28034914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Shin S. Viewing Legionella pneumophila pathogenesis through an immunological lens. J Mol Biol. 2019;431(21):4321–4344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31351897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Webster JD, Vucic D. The balance of TNF mediated pathways regulates inflammatory cell death signaling in healthy and diseased tissues. Front Cell Dev Biol. 2020;8:365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7326080</ArticleId>
            <ArticleId IdType="pubmed">32671059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahman MM, McFadden G. Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog. 2006;2(2):e4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1383482</ArticleId>
            <ArticleId IdType="pubmed">16518473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coers J, Vance RE, Fontana MF, et al. Restriction of Legionella pneumophila growth in macrophages requires the concerted action of cytokine and Naip5/Ipaf signalling pathways. Cell Microbiol. 2007;9(10):2344–2357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17506816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsiota-Bernard P, Lefebre C, Sedqui M, et al. Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes. Infect Immun. 1993;61(12):4980–4983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC281272</ArticleId>
            <ArticleId IdType="pubmed">8225572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skerrett SJ, Martin TR. Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila. Infect Immun. 1996;64(8):3236–3243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC174213</ArticleId>
            <ArticleId IdType="pubmed">8757859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawamoto Y, Morinaga Y, Kimura Y, et al. TNF-alpha inhibits the growth of Legionella pneumophila in airway epithelial cells by inducing apoptosis. J Infect Chemother. 2017;23(1):51–55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27865699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McHugh SL, Newton CA, Yamamoto Y, et al. Tumor necrosis factor induces resistance of macrophages to Legionella pneumophila infection. Proc Soc Exp Biol Med. 2000;224(3):191–196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10865236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cassier P, Campese C, Le Strat Y, et al. Epidemiologic characteristics associated with ST23 clones compared to ST1 and ST47 clones of Legionnaires disease cases in France. New Microbes New Infect. 2015;3:29–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4337934</ArticleId>
            <ArticleId IdType="pubmed">25755889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vandewalle-Capo M, Massip C, Descours G, et al. Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes. Int J Antimicrob Agents. 2017;50(5):684–689.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28782709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Copenhaver AM, Casson CN, Nguyen HT, et al. IL-1R signaling enables bystander cells to overcome bacterial blockade of host protein synthesis. Proc Natl Acad Sci U S A. 2015;112(24):7557–7562.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4475993</ArticleId>
            <ArticleId IdType="pubmed">26034289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tubach F, Ravaud P, Salmon-Ceron D, et al. Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists. Clin Infect Dis. 2006;43(10):e95–100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17051484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brieland JK, Remick DG, Freeman PT, et al. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect Immun. 1995;63(9):3253–3258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC173448</ArticleId>
            <ArticleId IdType="pubmed">7642253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skerrett SJ, Bagby GJ, Schmidt RA, et al. Antibody-mediated depletion of tumor necrosis factor-α impairs pulmonary host defenses to Legionella pneumophila. J Infect Dis. 1997;176(4):1019–1028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9333161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ziltener P, Reinheckel T, Oxenius A. Neutrophil and Alveolar macrophage-mediated innate immune control of Legionella pneumophila lung infection via TNF and ROS. PLoS Pathog. 2016;12(4):e1005591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4841525</ArticleId>
            <ArticleId IdType="pubmed">27105352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neumeister B, Kleihauer A, Rossmann V, et al. Induction of cytokines and expression of surface receptors in Mono Mac 6 cells after infection with different Legionella species. APMIS. 1998;106:319–333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9531966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Lu J, Li K, et al. The virulence of Legionella pneumophila is positively correlated with its ability to stimulate NF-kappaB activation. Future Microbiol. 2018;13:1247–1259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30238775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abu-Zant A, Santic M, Molmeret M, et al. Incomplete activation of macrophage apoptosis during intracellular replication of Legionella pneumophila. Infect Immun. 2005;73:5339–5349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1231138</ArticleId>
            <ArticleId IdType="pubmed">16113249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molmeret M, Zink SD, Han L, et al. Activation of caspase-3 by the Dot/Icm virulence system is essential for arrested biogenesis of the Legionella-containing phagosome. Cell Microbiol. 2004;6(1):33–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14678329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banga S, Gao P, Shen X, et al. Legionella pneumophila inhibits macrophage apoptosis by targeting pro-death members of the Bcl2 protein family. Proc Natl Acad Sci U S A. 2007;104(12):5121–5126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1829273</ArticleId>
            <ArticleId IdType="pubmed">17360363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu W, Hammad LA, Hsu F, et al. Induction of caspase 3 activation by multiple Legionella pneumophila Dot/Icm substrates. Cell Microbiol. 2013;15(11):1783–1795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3797225</ArticleId>
            <ArticleId IdType="pubmed">23773455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ge J, Xu H, Li T, et al. A Legionella type IV effector activates the NF-kappaB pathway by phosphorylating the IkappaB family of inhibitors. Proc Natl Acad Sci U S A. 2009;106(33):13725–13730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2728961</ArticleId>
            <ArticleId IdType="pubmed">19666608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Losick VP, Haenssler E, Moy MY, et al. LnaB: a Legionella pneumophila activator of NF-kappaB. Cell Microbiol. 2010;12(8):1083–1097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2947841</ArticleId>
            <ArticleId IdType="pubmed">20148897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ngwaga T, Hydock AJ, Ganesan S, et al. Potentiation of cytokine-mediated restriction of Legionella intracellular replication by a Dot/Icm-translocated effector. J Bacteriol. 2019; 201(14)1:e00755–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6597390</ArticleId>
            <ArticleId IdType="pubmed">31036725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin S, Case CL, Archer KA, et al. Type IV secretion-dependent activation of host MAP kinases induces an increased proinflammatory cytokine response to Legionella pneumophila. PLoS Pathog. 2008;4(11):e1000220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2582680</ArticleId>
            <ArticleId IdType="pubmed">19043549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ginevra C, Duclos A, Vanhems P, et al. Host-related risk factors and clinical features of community-acquired legionnaires disease due to the Paris and Lorraine endemic strains, 1998-2007, France. Clin Infect Dis. 2009;49(2):184–191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19508168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ginevra C, Chastang J, David S, et al. A real-time PCR for specific detection of the Legionella pneumophila serogroup 1 ST1 complex. Clin Microbiol Infect. 2020;26(4):514 e1–e6 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31525518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mentasti M, Cassier P, David S, et al. Rapid detection and evolutionary analysis of Legionella pneumophila serogroup 1 sequence type 47. Clin Microbiol Infect. 2017;23(4):264 e1–e9 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27915212</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35030980</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2150-5608</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Virulence</Title>
          <ISOAbbreviation>Virulence</ISOAbbreviation>
        </Journal>
        <ArticleTitle>TNF-α response in macrophages depends on clinical <i>Legionella pneumophila</i> isolates genotypes.</ArticleTitle>
        <Pagination>
          <StartPage>160</StartPage>
          <EndPage>173</EndPage>
          <MedlinePgn>160-173</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21505594.2021.2022861</ELocationID>
        <Abstract>
          <AbstractText>Legionnaires' Disease (LD) is a severe pneumonia mainly caused in Europe by <i>Legionella pneumophila</i> serogroup 1 (Lp1). Sequence-based typing methods reveal that some sequence types (ST) are overrepresented in clinical samples such as ST1 and ST47, suggesting that some strains are more fit for infection than others. In the present study, a collection of 108 Lp1 clinical isolates were used to evaluate the strain-dependent immune responses from human macrophages. Clinical Lp1 isolates induced differential TNFα secretion from macrophages. ST1 isolates induced a significantly higher TNF-α secretion than non-ST1, whereas ST47 isolates induced a significantly lower TNF-α secretion than non-ST47 isolates. ST1 isolates induced a significantly higher cell death than ST47 isolates evaluated by lactate dehydrogenase activity (cytotoxicity) and caspase-3 activity (apoptosis). Treatment of macrophages with anti-TNF-α antibodies significantly reduced the cell death in macrophages infected with ST1 or ST47 strains. The TNF-α secretion was neither explained by a differential bacterial replication nor by the number or type (bystander or infected) of TNF-α producing cells following infection but by a differential response from macrophages. The Paris ST1 reference strain elicited a significantly higher <i>TNF-α</i> gene transcription and a higher induction of NF-κB signaling pathway than the Lorraine ST47 reference strain.Clinical Lp1 isolates induce a diverse immune response and cell death, which could be related to the genotype. The two predominant sequence-types ST1 and ST47 trigger opposite inflammatory response that could be related to the host susceptibility.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Guillemot</LastName>
            <ForeName>Johann</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-5902-9188</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ginevra</LastName>
            <ForeName>Christophe</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-5597-094X</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hospices Civils de Lyon, Institut Des Agents Infectieux, Centre National de Référence Des Légionelles, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Allam</LastName>
            <ForeName>Camille</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0003-4585-4651</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hospices Civils de Lyon, Institut Des Agents Infectieux, Centre National de Référence Des Légionelles, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kay</LastName>
            <ForeName>Elisabeth</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0002-8763-7076</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gilbert</LastName>
            <ForeName>Christophe</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0003-3021-7350</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doublet</LastName>
            <ForeName>Patricia</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0001-5848-4317</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jarraud</LastName>
            <ForeName>Sophie</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-5750-0215</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Hospices Civils de Lyon, Institut Des Agents Infectieux, Centre National de Référence Des Légionelles, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chapalain</LastName>
            <ForeName>Annelise</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-3270-0947</Identifier>
            <AffiliationInfo>
              <Affiliation>Ciri, Centre International de Recherche En Infectiologie, Équipe Pathogenèse Des Légionelles, Université Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Virulence</MedlineTA>
        <NlmUniqueID>101531386</NlmUniqueID>
        <ISSNLinking>2150-5594</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000079424">Tumor Necrosis Factor Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016952" MajorTopicYN="Y">Legionella pneumophila</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007877" MajorTopicYN="Y">Legionnaires' Disease</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000079424" MajorTopicYN="N">Tumor Necrosis Factor Inhibitors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Legionella pneumophila</Keyword>
        <Keyword MajorTopicYN="Y">ST1</Keyword>
        <Keyword MajorTopicYN="Y">ST47</Keyword>
        <Keyword MajorTopicYN="Y">TNF-α</Keyword>
        <Keyword MajorTopicYN="Y">cell death</Keyword>
        <Keyword MajorTopicYN="Y">clinical isolates</Keyword>
        <Keyword MajorTopicYN="Y">immune response</Keyword>
        <Keyword MajorTopicYN="Y">macrophages</Keyword>
        <Keyword MajorTopicYN="Y">sequence type</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>15</Day>
          <Hour>5</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35030980</ArticleId>
        <ArticleId IdType="pmc">PMC8765069</ArticleId>
        <ArticleId IdType="doi">10.1080/21505594.2021.2022861</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Mondino S, Schmidt S, Rolando M, et al. Legionnaires’ disease: state of the art knowledge of pathogenesis mechanisms of Legionella. Annu Rev Pathol. 2020;15(1):439–466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31657966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chauhan D, Shames SR.. 
Pathogenicity and virulence of Legionella: intracellular replication and host response. Virulence. 2021;12(1):1122–1144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8043192</ArticleId>
            <ArticleId IdType="pubmed">33843434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campese C, Bitar D, Jarraud S, et al. Progress in the surveillance and control of Legionella infection in France, 1998-2008. Int J Infect Dis. 2011;15:e30–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21109475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lanternier F, Tubach F, Ravaud P, et al. Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study. Chest. 2013;144(3):990–998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23744173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beaute J. The European Legionnaires’ Disease Surveillance N. Legionnaires’ disease in Europe, 2011 to 2015. Euro Surveill. 2017;22(27). DOI:10.2807/1560-7917.ES.2017.22.27.30566</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.27.30566</ArticleId>
            <ArticleId IdType="pmc">PMC5508329</ArticleId>
            <ArticleId IdType="pubmed">28703097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cecchini J, Tuffet S, Sonneville R, et al. Antimicrobial strategy for severe community-acquired legionnaires’ disease: a multicentre retrospective observational study. J Antimicrob Chemother. 2017;72(5):1502–1509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28204479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chidiac C, Che D, Pires-Cronenberger S, et al. Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J. 2012;39(4):963–970.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22005914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cazalet C, Jarraud S, Ghavi-Helm Y, et al. Multigenome analysis identifies a worldwide distributed epidemic Legionella pneumophila clone that emerged within a highly diverse species. Genome Res. 2008;18(3):431–441.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2259107</ArticleId>
            <ArticleId IdType="pubmed">18256241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mercante JW, Caravas JA, Ishaq MK, et al. Genomic heterogeneity differentiates clinical and environmental subgroups of Legionella pneumophila sequence type 1. PLoS One. 2018;13(10):e0206110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6193728</ArticleId>
            <ArticleId IdType="pubmed">30335848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaia V, Fry NK, Afshar B, et al. Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila. J Clin Microbiol. 2005;43(5):2047–2052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1153775</ArticleId>
            <ArticleId IdType="pubmed">15872220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>David S, Rusniok C, Mentasti M, et al. Multiple major disease-associated clones of Legionella pneumophila have emerged recently and independently. Genome Res. 2016;26(11):1555–1564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5088597</ArticleId>
            <ArticleId IdType="pubmed">27662900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown AS, Yang C, Hartland EL, et al. The regulation of acute immune responses to the bacterial lung pathogen Legionella pneumophila. J Leukoc Biol. 2017;101(4):875–886.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28034914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Shin S. Viewing Legionella pneumophila pathogenesis through an immunological lens. J Mol Biol. 2019;431(21):4321–4344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31351897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Webster JD, Vucic D. The balance of TNF mediated pathways regulates inflammatory cell death signaling in healthy and diseased tissues. Front Cell Dev Biol. 2020;8:365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7326080</ArticleId>
            <ArticleId IdType="pubmed">32671059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahman MM, McFadden G. Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog. 2006;2(2):e4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1383482</ArticleId>
            <ArticleId IdType="pubmed">16518473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coers J, Vance RE, Fontana MF, et al. Restriction of Legionella pneumophila growth in macrophages requires the concerted action of cytokine and Naip5/Ipaf signalling pathways. Cell Microbiol. 2007;9(10):2344–2357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17506816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsiota-Bernard P, Lefebre C, Sedqui M, et al. Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes. Infect Immun. 1993;61(12):4980–4983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC281272</ArticleId>
            <ArticleId IdType="pubmed">8225572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skerrett SJ, Martin TR. Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila. Infect Immun. 1996;64(8):3236–3243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC174213</ArticleId>
            <ArticleId IdType="pubmed">8757859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kawamoto Y, Morinaga Y, Kimura Y, et al. TNF-alpha inhibits the growth of Legionella pneumophila in airway epithelial cells by inducing apoptosis. J Infect Chemother. 2017;23(1):51–55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27865699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McHugh SL, Newton CA, Yamamoto Y, et al. Tumor necrosis factor induces resistance of macrophages to Legionella pneumophila infection. Proc Soc Exp Biol Med. 2000;224(3):191–196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10865236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cassier P, Campese C, Le Strat Y, et al. Epidemiologic characteristics associated with ST23 clones compared to ST1 and ST47 clones of Legionnaires disease cases in France. New Microbes New Infect. 2015;3:29–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4337934</ArticleId>
            <ArticleId IdType="pubmed">25755889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vandewalle-Capo M, Massip C, Descours G, et al. Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes. Int J Antimicrob Agents. 2017;50(5):684–689.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28782709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Copenhaver AM, Casson CN, Nguyen HT, et al. IL-1R signaling enables bystander cells to overcome bacterial blockade of host protein synthesis. Proc Natl Acad Sci U S A. 2015;112(24):7557–7562.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4475993</ArticleId>
            <ArticleId IdType="pubmed">26034289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tubach F, Ravaud P, Salmon-Ceron D, et al. Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists. Clin Infect Dis. 2006;43(10):e95–100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17051484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brieland JK, Remick DG, Freeman PT, et al. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect Immun. 1995;63(9):3253–3258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC173448</ArticleId>
            <ArticleId IdType="pubmed">7642253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skerrett SJ, Bagby GJ, Schmidt RA, et al. Antibody-mediated depletion of tumor necrosis factor-α impairs pulmonary host defenses to Legionella pneumophila. J Infect Dis. 1997;176(4):1019–1028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9333161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ziltener P, Reinheckel T, Oxenius A. Neutrophil and Alveolar macrophage-mediated innate immune control of Legionella pneumophila lung infection via TNF and ROS. PLoS Pathog. 2016;12(4):e1005591.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4841525</ArticleId>
            <ArticleId IdType="pubmed">27105352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neumeister B, Kleihauer A, Rossmann V, et al. Induction of cytokines and expression of surface receptors in Mono Mac 6 cells after infection with different Legionella species. APMIS. 1998;106:319–333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9531966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Lu J, Li K, et al. The virulence of Legionella pneumophila is positively correlated with its ability to stimulate NF-kappaB activation. Future Microbiol. 2018;13:1247–1259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30238775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abu-Zant A, Santic M, Molmeret M, et al. Incomplete activation of macrophage apoptosis during intracellular replication of Legionella pneumophila. Infect Immun. 2005;73:5339–5349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1231138</ArticleId>
            <ArticleId IdType="pubmed">16113249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Molmeret M, Zink SD, Han L, et al. Activation of caspase-3 by the Dot/Icm virulence system is essential for arrested biogenesis of the Legionella-containing phagosome. Cell Microbiol. 2004;6(1):33–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14678329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banga S, Gao P, Shen X, et al. Legionella pneumophila inhibits macrophage apoptosis by targeting pro-death members of the Bcl2 protein family. Proc Natl Acad Sci U S A. 2007;104(12):5121–5126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1829273</ArticleId>
            <ArticleId IdType="pubmed">17360363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu W, Hammad LA, Hsu F, et al. Induction of caspase 3 activation by multiple Legionella pneumophila Dot/Icm substrates. Cell Microbiol. 2013;15(11):1783–1795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3797225</ArticleId>
            <ArticleId IdType="pubmed">23773455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ge J, Xu H, Li T, et al. A Legionella type IV effector activates the NF-kappaB pathway by phosphorylating the IkappaB family of inhibitors. Proc Natl Acad Sci U S A. 2009;106(33):13725–13730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2728961</ArticleId>
            <ArticleId IdType="pubmed">19666608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Losick VP, Haenssler E, Moy MY, et al. LnaB: a Legionella pneumophila activator of NF-kappaB. Cell Microbiol. 2010;12(8):1083–1097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2947841</ArticleId>
            <ArticleId IdType="pubmed">20148897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ngwaga T, Hydock AJ, Ganesan S, et al. Potentiation of cytokine-mediated restriction of Legionella intracellular replication by a Dot/Icm-translocated effector. J Bacteriol. 2019; 201(14)1:e00755–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6597390</ArticleId>
            <ArticleId IdType="pubmed">31036725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin S, Case CL, Archer KA, et al. Type IV secretion-dependent activation of host MAP kinases induces an increased proinflammatory cytokine response to Legionella pneumophila. PLoS Pathog. 2008;4(11):e1000220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2582680</ArticleId>
            <ArticleId IdType="pubmed">19043549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ginevra C, Duclos A, Vanhems P, et al. Host-related risk factors and clinical features of community-acquired legionnaires disease due to the Paris and Lorraine endemic strains, 1998-2007, France. Clin Infect Dis. 2009;49(2):184–191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19508168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ginevra C, Chastang J, David S, et al. A real-time PCR for specific detection of the Legionella pneumophila serogroup 1 ST1 complex. Clin Microbiol Infect. 2020;26(4):514 e1–e6 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31525518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mentasti M, Cassier P, David S, et al. Rapid detection and evolutionary analysis of Legionella pneumophila serogroup 1 sequence type 47. Clin Microbiol Infect. 2017;23(4):264 e1–e9 .</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27915212</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
